Fatigue, pain, and functional status during outpatient chemotherapy.
OBJECTIVE
To examine the relationship of fatigue and pain with functional status and the pattern of the two symptoms' occurrence over time in individuals with cancer who were receiving outpatient chemotherapy. The aims were to describe the levels of fatigue and pain with functional status and the inter-relationships with each other and with demographic and clinical variables over time.


METHODS
Descriptive, correlational.


METHODS
Outpatient chemotherapy clinic in the New England region of the United States.


METHODS
Total available population of 70 consecutive adult patients with breast cancer (n = 9), colorectal cancer (n = 21), lung cancer (n = 21), or lymphoma (n = 19).


METHODS
Retrospective data were extracted from the medical records; descriptive, correlational, and mixed-modeling methods were used to describe the sample and to examine the relationships of the symptoms and functional status.


METHODS
Fatigue, pain, functional status, and demographic and clinical factors.


RESULTS
Fatigue was the most frequently reported symptom; pain was rarely and almost exclusively reported by patients with lung cancer or lymphoma during their early treatments. Fatigue and functional status impairment were highly associated with each other and had similar relationships with the other variables.


CONCLUSIONS
The patterns and relationships of fatigue and functional status reported by this fairly healthy sample provide useful information to help guide early assessments and nursing interventions for people receiving outpatient chemotherapy.


CONCLUSIONS
The patterns and severity of symptoms and functional status impairment in people with colorectal cancer or lymphoma warrant further investigation. Targeted exercise interventions for specific outpatient populations should be developed and tested to address specific patterns of symptoms and functional status impairment in individuals with cancer.
Siefert
Mary Lou
ML
William F. Connell School of Nursing, Boston College, Chestnut Hill, MA, USA. mlsiefert@aya.yale.edu
D000203:Activities of Daily Living; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D004185:Disability Evaluation; D005221:Fatigue / Q000139:chemically induced* / Q000451:nursing; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D008223:Lymphoma / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D008297:Male; D008875:Middle Aged; D008960:Models, Psychological; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D009859:Oncology Nursing; D010045:Outpatients / Q000523:psychology; D010146:Pain / Q000139:chemically induced* / Q000451:nursing; D012189:Retrospective Studies
D000970:Antineoplastic Agents